Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORS for COVID-19 Prevention and Treatment
NCT04337918Phase 2Completed
- Sponsor
- SaNOtize
- Start
- May 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in coronavirus disease 2019 (COVID-19), sponsored by SaNOtize. Started May 2020; status: completed.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04337918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04337918.